Korro Bio and Genevant Sciences Enter Into Collaboration Agreement to Develop RNA Editing Therapeutic for Alpha-1 Antitrypsin Deficiency
Collaboration to combine Korro’s RNA editing technology and Genevant’s LNP technology CAMBRIDGE, MA, VANCOUVER, BC, and BASEL, CH — Korro Bio, a leading RNA editing company focused on the discovery and… Read More



